[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR112016012325A2 - métodos para amidação c-terminal in vivo de um polipeptídeo e para a produção recombinante de um polipeptídeo e uso de uma peptidilglicina - Google Patents

métodos para amidação c-terminal in vivo de um polipeptídeo e para a produção recombinante de um polipeptídeo e uso de uma peptidilglicina

Info

Publication number
BR112016012325A2
BR112016012325A2 BR112016012325A BR112016012325A BR112016012325A2 BR 112016012325 A2 BR112016012325 A2 BR 112016012325A2 BR 112016012325 A BR112016012325 A BR 112016012325A BR 112016012325 A BR112016012325 A BR 112016012325A BR 112016012325 A2 BR112016012325 A2 BR 112016012325A2
Authority
BR
Brazil
Prior art keywords
polypeptide
vivo
peptidylglycine
methods
terminal amidation
Prior art date
Application number
BR112016012325A
Other languages
English (en)
Inventor
Hoffmann Eike
Tiefenthaler Georg
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR112016012325A2 publication Critical patent/BR112016012325A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/17—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced ascorbate as one donor, and incorporation of one atom of oxygen (1.14.17)
    • C12Y114/17003—Peptidylglycine monooxygenase (1.14.17.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y403/00—Carbon-nitrogen lyases (4.3)
    • C12Y403/02—Amidine-lyases (4.3.2)
    • C12Y403/02005—Peptidylamidoglycolate lyase (4.3.2.5)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

um aspecto conforme relatado no presente pedido é o método para amidação c-terminal in vivo de um polipeptídeo, caracterizado pelo fato de tanto o polipeptídeo (a ser amidado) como a peptidilglicina alfa-amidante monooxigenase (pam) serem coexpressos de forma recombinante em uma célula de mamífero.
BR112016012325A 2013-12-20 2014-12-10 métodos para amidação c-terminal in vivo de um polipeptídeo e para a produção recombinante de um polipeptídeo e uso de uma peptidilglicina BR112016012325A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13199222 2013-12-20
PCT/EP2014/077143 WO2015091131A1 (en) 2013-12-20 2014-12-10 Use of peptidylglycine alpha-amidating monooxigenase (pam) for c-terminal amidation

Publications (1)

Publication Number Publication Date
BR112016012325A2 true BR112016012325A2 (pt) 2017-09-26

Family

ID=49885043

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016012325A BR112016012325A2 (pt) 2013-12-20 2014-12-10 métodos para amidação c-terminal in vivo de um polipeptídeo e para a produção recombinante de um polipeptídeo e uso de uma peptidilglicina

Country Status (10)

Country Link
US (1) US20160333386A1 (pt)
EP (1) EP3083662A1 (pt)
JP (1) JP2017507645A (pt)
KR (1) KR20160098278A (pt)
CN (1) CN105793278A (pt)
BR (1) BR112016012325A2 (pt)
CA (1) CA2928927A1 (pt)
MX (1) MX2016007202A (pt)
RU (1) RU2016129516A (pt)
WO (1) WO2015091131A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023515981A (ja) * 2020-02-26 2023-04-17 ペーアーエム セラノスティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング ペプチジルグリシンαアミド化モノオキシゲナーゼ（ＰＡＭ）を決定する方法および診断目的でのその使用
US20230149516A1 (en) * 2020-02-26 2023-05-18 Pam Theragnostics Gmbh Use of peptidylglycine alpha-amidating monooxygenase (pam) for therapeutic purpose

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8660701A1 (es) * 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
US8008453B2 (en) * 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
JP5931738B2 (ja) * 2009-12-01 2016-06-08 ノヴォ ノルディスク アー／エス 新規のペプチジルアルファ−ヒドロキシグリシンアルファ−アミド化リアーゼ

Also Published As

Publication number Publication date
MX2016007202A (es) 2016-07-21
WO2015091131A1 (en) 2015-06-25
CN105793278A (zh) 2016-07-20
CA2928927A1 (en) 2015-06-25
JP2017507645A (ja) 2017-03-23
KR20160098278A (ko) 2016-08-18
EP3083662A1 (en) 2016-10-26
RU2016129516A (ru) 2018-01-25
US20160333386A1 (en) 2016-11-17

Similar Documents

Publication Publication Date Title
BR112018007017A2 (pt) polipeptídeos
MX2016008539A (es) Variantes de region fc con propiedades de union a receptor fc neonatal (fcrn) modificadas y de union a proteina a mantenidas.
NZ711445A (en) Fusion immunomodulatory proteins and methods for making same
MX2015012553A (es) Variantes de fc.
MX2016008540A (es) Variantes de region fc con propiedades de union al receptor fc neonatal (fcrn).
TR201909037T4 (tr) Yeni protein deamidaz.
ZA201805630B (en) Cell culture compositions with antioxidants and methods for polypeptide production
MX2015016835A (es) Metodo para reticular acido hialuronico; metodo para preparar un hidrogel inyectable; el hidrogel obtenido; el uso del hidrogel obtenido.
BR112016002622A2 (pt) meio e processo de cultura celular, polipeptídeo, uso de selênio ou de um sal do mesmo e uso de zinco ou um sal do mesmo
BR112014016683A2 (pt) células de levedura geneticamente projetadas
EA201791275A1 (ru) Способы получения ctp-модифицированных полипептидов длительного действия
MX371025B (es) Células eucariotas novedosas y métodos para la expresión recombinante de un producto de interés.
MX2020012356A (es) Sobreexpresion de reguladores de la ruta de n-glicosilacion para modular la glicosilacion de proteinas recombinantes.
AU2014213134B2 (en) Recombinant yeast transformant and process for preparing immunoglobulin Fc fragment employing the same
PE20151206A1 (es) Polipeptidos del factor vii de accion corta
BR112016012325A2 (pt) métodos para amidação c-terminal in vivo de um polipeptídeo e para a produção recombinante de um polipeptídeo e uso de uma peptidilglicina
MX2016005572A (es) Uso de monensina para regular la glicosilacion de proteinas recombinantes.
BR112014021326A2 (pt) célula para a expressão de protéina, método para reduzir a atividade de amidação de peptídeo em uma determinada célula, uso de uma célula
MX2018007298A (es) Variantes con mejores propiedades de polipéptidos de fusión relacionados con omega-hidroxilasa.
BR112018005464A2 (pt) expressão de proteínas contendo fc
BR112017009189A2 (pt) célula hospedeira recombinante expressando atividade de beta-galactosidase e/ou transgalactosilante deficiente em mananase, celulase e pectinase
PL3041962T3 (pl) Sposób garbowania do wytwarzania skóry o bardzo elastycznych właściwościach oraz otrzymana skóra
BR112015026845A2 (pt) barco com capota rígida móvel retrátil
HK1221977A1 (zh) 用於產生供生產重組蛋白的哺乳動物生產細胞的物品和方法
HK1221742A1 (zh) 用於在原核細胞中重組生產多肽的方法

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS.

B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2544 DE 08-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]